30-Apr-2024
Quarterly Activities/Appendix 4C Cash Flow Report
29-Apr-2024
Notice of Annual General Meeting/Proxy Form
19-Apr-2024
Application for quotation of securities - EXL
18-Apr-2024
Results of Meeting
8-Apr-2024
Application for quotation of securities - EXL
4-Apr-2024
Becoming a substantial holder
3-Apr-2024
Appendix 3Z - Ronald Dufficy
3-Apr-2024
Appendix 3X - Natalie Butler
3-Apr-2024
Appendix 3Y - David Fenlon
3-Apr-2024
Appendix 3Y - Ronald Dufficy
3-Apr-2024
Notification of cessation of securities - EXL
3-Apr-2024
Date of Annual General Meeting
28-Mar-2024
EOF: Sale of Ananda Food
28-Mar-2024
Completion of Ananda Food acquisition and Executive Changes
25-Mar-2024
Application for quotation of securities - EXL
22-Mar-2024
Security Class Reinstatement to Quotation
22-Mar-2024
Top 20 securityholders - Listed Options
22-Mar-2024
Application for quotation of securities - EXL
20-Mar-2024
Results of Fully Underwritten Rights Issue Offer
20-Mar-2024
Notice of Extraordinary General Meeting
18-Mar-2024
Security Class Suspension from Quotation
13-Mar-2024
Non-Renounceable Rights Issue Offer Closing Date Reminder
12-Mar-2024
Corporate Governance Statement and Appendix 4G
12-Mar-2024
FY23 Annual Report
7-Mar-2024
Mt Elephant Distribution
29-Feb-2024
FY23 Results Presentation
29-Feb-2024
FY23 Results Announcement
29-Feb-2024
FY23 Appendix 4E - Preliminary Final Report
26-Feb-2024
Dispatch of prospectus
20-Feb-2024
Binding Agreement to Divest Non-core Asset
19-Feb-2024
Optionholder Letter - Non-Renounceable Rights Issue Offer
19-Feb-2024
Prospectus - Non-Renounceable Rights Issue Offer
14-Feb-2024
Lifting of Trading Halt
14-Feb-2024
Update - Proposed issue of securities - EXL
14-Feb-2024
Substantial Interest in Entitlement Offer Shortfall
13-Feb-2024
Proposed issue of securities - EXL
12-Feb-2024
Ananda Food Acquisition and Capital Raising Presentation
12-Feb-2024
Ananda Food Acquisition and Proposed Capital Raising
12-Feb-2024
Sale of hemp food and animal products business
12-Feb-2024
Trading Halt
9-Feb-2024
Appendix 3Y - Ronald Dufficy
9-Feb-2024
Notification of cessation of securities - EXL
31-Jan-2024
Quarterly Activities/Appendix 4C Cash Flow Report
16-Jan-2024
Notification of cessation of securities - EXL
27-Nov-2023
Change of Phone Number
23-Nov-2023
Appendix 3Y - Ronald Dufficy
23-Nov-2023
Appendix 3Y - David Fenlon
23-Nov-2023
Cleansing Notice
23-Nov-2023
Notification regarding unquoted securities - EXL
23-Nov-2023
Application for quotation of securities - EXL
30-Oct-2023
Quarterly Update & Appendix 4C
25-Oct-2023
Investor Presentation October 2023
23-Oct-2023
Notification of cessation of securities - EXL
18-Oct-2023
Appendix 3Y - Pauline Gately
3-Oct-2023
Notification regarding unquoted securities - EXL
3-Oct-2023
Appendix 3Y - Ronald Dufficy
3-Oct-2023
Application for quotation of securities - EXL
3-Oct-2023
Appendix 3Z - Helen Wiseman
3-Oct-2023
Appendix 3Y - Helen Wiseman
3-Oct-2023
Notification of cessation of securities - EXL
2-Oct-2023
Director Resignation and Appointment of new Chair
4-Sep-2023
Appendix 3Y - Ronald Dufficy
4-Sep-2023
Appendix 3Y - David Fenlon
4-Sep-2023
Appendix 3Y - Helen Wiseman
1-Sep-2023
Cleansing Notice
31-Aug-2023
Notification regarding unquoted securities - EXL
31-Aug-2023
Application for quotation of securities - EXL
30-Aug-2023
H1 FY2023 Results Presentation
30-Aug-2023
H1 FY2023 Results Announcement
30-Aug-2023
H1 FY2023 Appendix 4D and Interim Report
23-Aug-2023
Ceasing to be a substantial holder
17-Aug-2023
Appendix 3X - Pauline Gately
17-Aug-2023
Notification regarding unquoted securities - EXL
17-Aug-2023
Application for quotation of securities - EXL
17-Aug-2023
Application for quotation of securities - EXL
17-Aug-2023
Implementation of Scheme of Arrangement with TSN
8-Aug-2023
Lodgement of Court Orders - Scheme becomes effective
8-Aug-2023
TSN: Lodgement of Court Orders - Scheme becomes effective
7-Aug-2023
Proposed issue of securities - EXL
7-Aug-2023
Court approves Scheme of Arrangement
7-Aug-2023
TSN: Court Approves Scheme
2-Aug-2023
TSN Results from Scheme Meeting
31-Jul-2023
Quarterly Activities/Appendix 4C Cash Flow Report
7-Jul-2023
Notification of cessation of securities - EXL
29-Jun-2023
Scheme Booklet registered with ASIC
29-Jun-2023
TSN: Scheme Booklet registered by ASIC
29-Jun-2023
TSN: Court orders convening of Scheme Meeting
29-Jun-2023
Update on Proposed Scheme of Arrangement
20-Jun-2023
TSN: Update on Scheme of Arrangement with EXL
20-Jun-2023
Update on Proposed Scheme of Arrangement
13-Jun-2023
Appendix 3Y - Ronald Dufficy
13-Jun-2023
Appendix 3Y - Helen Wiseman
8-Jun-2023
Notification regarding unquoted securities - EXL
7-Jun-2023
Correction to Directors Interest Notices
7-Jun-2023
Cleansing Notice
7-Jun-2023
Application for quotation of securities - EXL
7-Jun-2023
Application for quotation of securities - EXL
6-Jun-2023
Proposed issue of securities - EXL
5-Jun-2023
Appendix 3Y - Ronald Dufficy
1-Jun-2023
2023 AGM - AGM Recording
31-May-2023
Application for quotation of securities - EXL
31-May-2023
Appendix 3Y - Ronald Dufficy
31-May-2023
Appendix 3Y - David Fenlon
31-May-2023
Appendix 3Y - Helen Wiseman
31-May-2023
Notification regarding unquoted securities - EXL
31-May-2023
Notification regarding unquoted securities - EXL
31-May-2023
Amended Constitution
31-May-2023
2023 AGM - Voting Results
31-May-2023
2023 AGM - Chair's Address
31-May-2023
2023 AGM - CEO's Presentation
26-May-2023
Application for quotation of securities - EXL
24-May-2023
Completion of Underwritten Share Purchase Plan
23-May-2023
Company Secretary Appointment/Resignation
17-May-2023
TSN: Update on Scheme of Arrangement with EXL
17-May-2023
Update on Proposed Schemes of Arrangement
1-May-2023
Target Market Determination
1-May-2023
SPP BOOKLET AND OPTIONS PROSPECTUS
28-Apr-2023
Update - Proposed issue of securities - EXL
28-Apr-2023
Notice of Annual General Meeting
28-Apr-2023
SPP Underwriting Agreement
28-Apr-2023
Quarterly Update & Appendix 4C
27-Apr-2023
Application for quotation of securities - EXL
21-Apr-2023
TSN: Update on schemes of Arrangement with Elixinol
21-Apr-2023
Notification regarding unquoted securities - EXL
21-Apr-2023
Update - Schemes of Arrangement
20-Apr-2023
Proposed issue of securities - EXL
19-Apr-2023
Company Secretary Appointment/Resignation
14-Apr-2023
Correction to ASX Announcement - Cleansing Notice
14-Apr-2023
Application for quotation of securities - EXL
14-Apr-2023
Cleansing Notice
13-Apr-2023
Application for quotation of securities - EXL
6-Apr-2023
Appendix 3X - Ronald Dufficy
6-Apr-2023
Final Directors Interest Notice - Oliver Horn
6-Apr-2023
Final Directors Interest Notice - Paul Benhaim
6-Apr-2023
Notification of cessation of securities - EXL
6-Apr-2023
Board Changes
5-Apr-2023
TSN: Schemes of Arrangement Timetable Update
5-Apr-2023
Proposed issue of securities - EXL
5-Apr-2023
EXL Successfully Completes Placement & Launches SPP
3-Apr-2023
Trading Halt
24-Mar-2023
AGM Date Change
28-Feb-2023
AGM Date
28-Feb-2023
Appendix 3Y
28-Feb-2023
FY2022 Results Announcement
28-Feb-2023
Corporate Governance Statement and Appendix 4G
27-Feb-2023
FY2022 Appendix 4E and Annual Report
14-Feb-2023
Elixinol Wellness Successful in International Arbitration
31-Jan-2023
Quarterly Update and Appendix 4C
6-Jan-2023
Appendix 3Y - Helen Wiseman
6-Jan-2023
Appendix 3Y - Paul Benhaim
6-Jan-2023
Appendix 3Y - David Fenlon
6-Jan-2023
Appendix 3Y - Oliver Horn
6-Jan-2023
Notification of cessation of securities - EXL
30-Nov-2022
Ceasing to be a substantial holder
30-Nov-2022
Proposed issue of securities - EXL
29-Nov-2022
TSN: Schemes of Arrangement with Elixinol Wellness Ltd
29-Nov-2022
Proposed Acquisition of The Sustainable Nutrition Group Ltd
20-Oct-2022
Quarterly Update and Appendix 4C
5-Oct-2022
Notification of cessation of securities - EXL
29-Sep-2022
Change in substantial holding
30-Aug-2022
H1 FY2022 Results Presentation
30-Aug-2022
H1 FY2022 Results Announcement
30-Aug-2022
H1 FY2022 Appendix 4D and Interim Report
29-Jul-2022
Quarterly Update and Appendix 4C
27-Jul-2022
Change in substantial holding
8-Jul-2022
Notification of cessation of securities - EXL
7-Jun-2022
Change in substantial holding
27-May-2022
Notification regarding unquoted securities - EXL
26-May-2022
2022 AGM - Audio Recording
26-May-2022
2022 AGM - Voting Results
26-May-2022
2022 AGM - CEO Presentation
26-May-2022
2022 AGM Chairs Address
29-Apr-2022
Quarterly Update and Appendix 4C
22-Apr-2022
Notice of Annual General Meeting
4-Apr-2022
Appendix 3X - David Fenlon
28-Mar-2022
Strategic Review Update
1-Mar-2022
Application for quotation of securities - EXL
28-Feb-2022
AGM Date
25-Feb-2022
FY2021 Results Presentation
25-Feb-2022
FY2021 Results Announcement
25-Feb-2022
Corporate Governance Statement and Appendix 4G
25-Feb-2022
Annual Report
25-Feb-2022
FY2021 Appendix 4E
10-Feb-2022
Margin Loan Facility Concluded - Mr Banhaim
10-Feb-2022
Change in Substantial Holding - Paul Benhaim
31-Jan-2022
Quarterly Update and Appendix 4C
21-Jan-2022
Notification regarding unquoted securities - EXL
12-Jan-2022
Notification of cessation of securities - EXL
30-Dec-2021
Change in Substantial Holding - Paul Benhaim
30-Dec-2021
Appendix 3Y - Paul Benhaim
6-Dec-2021
Change in Substantial Holding - Paul Benhaim
6-Dec-2021
Appendix 3Y - Paul Benhaim
1-Nov-2021
Jobkeeper Payments Notice
22-Oct-2021
Appendix 2A
21-Oct-2021
Appendix 3Y - Oliver Horn
21-Oct-2021
Application for quotation of securities - EXL
19-Oct-2021
Appendix 3Y - Helen Wiseman
15-Oct-2021
Quarterly Update and Appendix 4C
13-Oct-2021
Notification of cessation of securities - EXL
1-Sep-2021
Application for quotation of securities - EXL
17-Aug-2021
H1 FY2021 Results Presentation
17-Aug-2021
H1 FY2021 Results Announcement
17-Aug-2021
H1 FY2021 Appendix 4D and Interim Report
22-Jul-2021
Quarterly Update & Appendix 4C
7-Jul-2021
Notification regarding unquoted securities - EXL
1-Jul-2021
EXL Presenting at ShareCafe Small Cap Hidden Gems Webinar
29-Jun-2021
Cancel - Proposed issue of securities - EXL
29-Jun-2021
Termination of Proposed CannaCare Health Acquisition
28-Jun-2021
Trading Halt
15-Jun-2021
EXL Presenting at Australian Micro & Small Cap Conference
9-Jun-2021
Distribution Expansion in Australian CBD Market
9-Jun-2021
HHI: Health House signs distribution agreement with Elixinol
1-Jun-2021
Appendix 2A
17-May-2021
Elixinol Changes its Name
17-May-2021
2021 AGM - Audio Recording
17-May-2021
2021 AGM - Voting Results
17-May-2021
2021 AGM - CEO Presentation
17-May-2021
2021 AGM - Chair's Address
27-Apr-2021
Investor Presentation
26-Apr-2021
Quarterly Update & Appendix 4C
15-Apr-2021
Notice of Annual General Meeting
25-Mar-2021
Positive Update on Novel Foods Application
18-Mar-2021
Investor Presentation Recording
16-Mar-2021
Investor Briefing & Investor Presentation
15-Mar-2021
AGM Date and Joint Company Secretary
15-Mar-2021
Proposed issue of Securities - EXL
15-Mar-2021
Reinstatement to Official Quotation
15-Mar-2021
Elixinol to Acquire 100% of CannaCare Health
8-Mar-2021
Suspension from Official Quotation
4-Mar-2021
Trading Halt
4-Mar-2021
Pause in Trading
3-Mar-2021
Appendix 2A
26-Feb-2021
Corporate Governance Statement and Appendix 4G
26-Feb-2021
FY2020 Results Announcement
26-Feb-2021
Annual Report
26-Feb-2021
FY2020 Appendix 4E
5-Feb-2021
Change in substantial holding
4-Feb-2021
Appendix 3Y - Oliver Horn
4-Feb-2021
Appendix 2A
27-Jan-2021
Quarterly Update & Appendix 4C
18-Jan-2021
Change in substantial holding
4-Jan-2021
Change in substantial holding
30-Dec-2020
Change in substantial holding
24-Dec-2020
Response to ASX Aware Query
21-Dec-2020
Change in Substantial Holding - Paul Benhaim
21-Dec-2020
Business Update
21-Dec-2020
Pet Releaf Supply Agreement Terminated
18-Dec-2020
Appendix 3Y - Oliver Horn
18-Dec-2020
Appendix 3Y - Helen Wiseman
18-Dec-2020
Appendix 2A
16-Dec-2020
Oversubscribed Share Purchase Plan
14-Dec-2020
Change in substantial holding
4-Dec-2020
Share Purchase Plan Update
3-Dec-2020
United Nations Reschedules Cannabis
30-Nov-2020
Change in substantial holding
24-Nov-2020
Becoming a substantial holder
23-Nov-2020
Change in Substantial Holding - Paul Benhaim
20-Nov-2020
Share Purchase Plan
20-Nov-2020
Appendix 2A
20-Nov-2020
Cleansing Statement
20-Nov-2020
Update - Proposed issue of Securities - EXL
19-Nov-2020
Response to ASX Query Letter
16-Nov-2020
Proposed issue of Securities - EXL
16-Nov-2020
Completion of Institutional Offer
13-Nov-2020
Trading Halt
13-Nov-2020
Change in Substantial Holding - Paul Benhaim
13-Nov-2020
Appendix 3Y - Paul Benhaim
13-Nov-2020
Appendix 3Y - Paul Benhaim
13-Nov-2020
Ceasing to be a Substantial Holder - D&G Health
13-Nov-2020
Change in Substantial Holding - D&G Health
10-Nov-2020
Response to ASX Price Query (updated)
10-Nov-2020
Response to ASX Price Query(updated)
9-Nov-2020
Response to ASX Price Query
29-Oct-2020
Investor Briefing Video Recording
27-Oct-2020
Investor Presentation
27-Oct-2020
Quarterly Update & Appendix 4C
27-Oct-2020
Correction to Appendix 3G
22-Oct-2020
Appendix 3G
22-Oct-2020
Revised Securities Trading Policy
30-Sep-2020
Appendix 3Y - Helen Wiseman
29-Sep-2020
Appendix 3Y - Oliver Horn
25-Sep-2020
Change of Share Registry
22-Sep-2020
Elixinol Trading Update
18-Sep-2020
Appendix 3Y - Paul Benhaim
18-Sep-2020
Appendix 3Y - Paul Benhaim
14-Sep-2020
H1 FY2020 Interim Report Announcement
14-Sep-2020
H1 FY2020 Interim Report
10-Sep-2020
Elixinol Appoints New Chair
31-Aug-2020
H1 FY2020 Results ASX Announcement
31-Aug-2020
H1 FY2020 Results Presentation
31-Aug-2020
H1 FY2020 Appendix 4D Preliminary Interim Report
4-Aug-2020
Quarterly Activities Report Addendum
31-Jul-2020
2020 AGM Audio Recording
30-Jul-2020
Appendix 3Y - Oliver Horn
30-Jul-2020
Appendix 3Y - Helen Wiseman
30-Jul-2020
Appendix 3G
30-Jul-2020
AGM RESULTS
30-Jul-2020
2020 AGM - CEO Presentation
30-Jul-2020
2020 AGM - Chairman's Address
30-Jul-2020
Quarterly Update & Appendix 4C
29-Jul-2020
Appointment of New Auditor
28-Jul-2020
EXL enters into exclusive License Agreement in Japan
27-Jul-2020
PharmaCann to Distribute Elixinol Products in Australia
30-Jun-2020
Notice of Annual General Meeting & Proxy Form
17-Jun-2020
Appendix 3Y - Paul Benhaim
11-Jun-2020
Notice of Annual General Meeting (AGM)
2-Jun-2020
D&G Health - Change of Substantial Holder
1-Jun-2020
Raw with Life - Change of Substantial Holder
1-Jun-2020
Appendix 2A
26-May-2020
EXL Successfully Completes Retail Entitlement Offer
25-May-2020
HFA Sale Termination
13-May-2020
Appendix 2A
12-May-2020
Despatch of Retail Entitlement Offer Booklet
12-May-2020
Notification to ineligible shareholders
11-May-2020
Class Action Dismissed
7-May-2020
Sale of Nunyara Land
6-May-2020
Completion of Institutional Offer
5-May-2020
Investor Conference Call Recording
5-May-2020
Cleansing Statement
5-May-2020
Appendix 3B
5-May-2020
Investor Presentation
5-May-2020
Elixinol Announces Capital Raising
30-Apr-2020
Quarterly Update & Appendix 4C
30-Apr-2020
Trading Halt
27-Apr-2020
Group CEO Update
27-Apr-2020
Appendix 3X - Helen Wiseman
27-Apr-2020
Appendix 3Z - Stratos Karousos
21-Apr-2020
Elixinol Global appoints new CEO and Strengthens Board
7-Apr-2020
Initial Director's Interest Notice for Mr Horn
7-Apr-2020
Final Director's Interest Notice for Mr Ellery
7-Apr-2020
Final Director's Interest Notice for Mr Duff
6-Apr-2020
Changes to the Board
30-Mar-2020
Global Rebrand & New Products
30-Mar-2020
Corporate Governance Statement and Appendix 4G
30-Mar-2020
Annual Report
27-Feb-2020
FY2019 Investor Results Presentation
27-Feb-2020
FY2019 Results ASX Announcement
27-Feb-2020
FY2019 Appendix 4E Preliminary Financial Report
6-Feb-2020
Response to ASX Appendix 4C Query Letter
3-Feb-2020
Sale of HFA and Nunyara Update
31-Jan-2020
Quarterly Update and Appendix 4C
21-Jan-2020
Response to ASX Price Query
14-Jan-2020
Appendix 3Y - Paul Benhaim
14-Jan-2020
Raw with Life - Change of Substantial Holder
8-Jan-2020
Appendix 2A - Release of Escrowed Securities
18-Dec-2019
Resignation of Chief Innovation Officer
18-Dec-2019
Mandatory Escrowed Securities to be Released
17-Dec-2019
Market Update
5-Dec-2019
Elixinols Comments on Potential Class Action
2-Dec-2019
Elixinol Japan Update
15-Nov-2019
Response to ASX Price Query
4-Nov-2019
Appointment of Global General Counsel and Company Secretary
29-Oct-2019
Quarterly Report and Appendix 4C
23-Oct-2019
Market Update Elixinol Japan Operations
21-Oct-2019
Trading Halt
21-Oct-2019
Pause in Trading
2-Oct-2019
Upcoming U.S. Investor Conferences
26-Sep-2019
Exclusive Distribution Agreement for Finland
23-Sep-2019
Appendix 3B
30-Aug-2019
Exclusive distribution agreement for Belgium & Luxembourg
29-Aug-2019
H1 FY2019 Results Presentation
29-Aug-2019
H1 FY2019 Results Announcement
29-Aug-2019
Appendix 4D and Interim Report
8-Aug-2019
Exclusive CBD supply agreement with Pet Releaf
30-Jul-2019
Quarterly Report and Appendix 4C
29-Jul-2019
Elixinol partners with PharmaCare
23-Jul-2019
Elixinol continues to build Leadership team
22-Jul-2019
Global IP rights for microencapsulation technology acquired
18-Jul-2019
Final Directors Interest Notice - Linda McLeod
18-Jul-2019
Initial Directors Interest Notice - Stratos Karousos
17-Jul-2019
Nunyara Manufacturing Licence
16-Jul-2019
Leadership and Group Structure update
4-Jul-2019
MedVec Distribution Agreement Signed
12-Jun-2019
D&G Health Change of Substantial Holder
12-Jun-2019
Raw with Life Change of Substantial Holder
12-Jun-2019
EXL Change of Substantial Holder
12-Jun-2019
Cleansing Statement and Appendix 3B
11-Jun-2019
Strategic Partnership with RFI
5-Jun-2019
Elixinol Global raises A$50m to accelerate US expansion
4-Jun-2019
Trading Halt
24-May-2019
Appendix 3B
24-May-2019
Final Directors Interest Notice
23-May-2019
AGM Results
23-May-2019
2019 AGM CEO Presentation
23-May-2019
2019 AGM Chairmans address
21-May-2019
Updated investor presentation May 2019
14-May-2019
EXL granted New York State CBD Authorization
13-May-2019
Investor Presentation May 2019
7-May-2019
Waiver from Listing Rule 14.7
24-Apr-2019
Cleansing Statement
24-Apr-2019
Appendix 3B
24-Apr-2019
Independent Valuation Report
24-Apr-2019
Elixinol acquires 25% of US based Pet Releaf
23-Apr-2019
Quarterly Report and Appendix 4C
18-Apr-2019
Notice of Annual General Meeting/Proxy Form
18-Apr-2019
Executive team expanded and Board change
18-Apr-2019
Initial Director's Interest Notice - Greg Ellery
12-Apr-2019
Appointment of Greg Ellery
28-Mar-2019
Corporate Governance Statement and Appendix 4G
28-Mar-2019
Annual Report
13-Mar-2019
Investor Update March/April 2019
11-Mar-2019
2019 Annual General Meeting
27-Feb-2019
Full Year Results Presentation Conference Call Recording
26-Feb-2019
FY 2018 Investor Results Presentation
26-Feb-2019
FY 2018 Results ASX Announcement
26-Feb-2019
FY 2018 Appendix 4E Preliminary Financial Report
21-Feb-2019
Elixinol FY2018 Results conference call
7-Feb-2019
Nunyara land purchase
5-Feb-2019
EXL expands into Europe driving international growth
31-Jan-2019
Quarterly Report and Appendix 4C
23-Jan-2019
Elixinol enters New Zealand market
8-Jan-2019
CFO relocation and appointment of Joint Company Secretary
27-Dec-2018
Appendix 3B - Release of Escrowed Securities
21-Dec-2018
2018 Farm Bill signed by the US President
13-Dec-2018
EXL Investor Newsletter
11-Dec-2018
Release of Restricted Securities
6-Nov-2018
Elixinol Global completes 50.5% investment in Elixinol Japan
5-Nov-2018
Raw with Life Change of Substantial Holder
5-Nov-2018
D&G Health Change of Substantial Holder
5-Nov-2018
EXL Change of Substantial Holder
1-Nov-2018
Appendix 3B
31-Oct-2018
EXL Sydney Wholesale Investor Presentation
30-Oct-2018
Quarterly Report and Appendix 4C
17-Oct-2018
EXL Aust Microcap Investment Conference Presentation
4-Oct-2018
Cleansing Statement and Appendix 3B
28-Sep-2018
Elixinol Global raises A$40m to accelerate international gro
26-Sep-2018
Trading Halt
24-Sep-2018
EXL increases ownership in Elixinol Japan
18-Sep-2018
EXL Commences Trading on OTCQX Market in United States
6-Sep-2018
EXL Presentation for Investor Briefings September 2018
30-Aug-2018
1H FY2018 Results Conference Call Recording
29-Aug-2018
1H 2018 Investor Results Presentation
29-Aug-2018
1H 2018 Results ASX Announcement
29-Aug-2018
Appendix 4D and 1H 2018 Interim Report
24-Aug-2018
Elixinol Global 1H FY2018 results conference call
30-Jul-2018
Quarterly Report and Appendix 4C
29-Jun-2018
Historic US Hemp Farming Legislation Passed
17-May-2018
Change of Director's Interest Notice - S Karousos
17-May-2018
Change of Director's Interest Notice - P Benhaim
17-May-2018
Change of Directors Interest Notice - L McLeod
17-May-2018
Change of Directors Interest Notice A Duff
15-May-2018
Appendix 3B
15-May-2018
2017 AGM Results
15-May-2018
2017 AGM Presentation
15-May-2018
2017 AGM Chairmans address
30-Apr-2018
Quarterly Report and Appendix 4C
24-Apr-2018
Elixinol enters into Joint Venture
12-Apr-2018
Notice of Annual General Meeting & Proxy Form
3-Apr-2018
Appendix 3B
28-Feb-2018
FY2017 Investor Results Presentation
28-Feb-2018
FY2017 Results ASX Announcement
28-Feb-2018
Corporate Governance Statement and Appendix 4G
28-Feb-2018
Appendix 4E and 2017 Annual Report
31-Jan-2018
Appendix 4C - quarterly
11-Jan-2018
Initial Director's Interest Notice - S Karousos
11-Jan-2018
Initial Director's Interest Notice - L McLeod
11-Jan-2018
Initial Director's Interest Notice - P Benhaim
11-Jan-2018
Initial Director's Interest Notice - A Duff
10-Jan-2018
Substantial Shareholder Notice - DG
10-Jan-2018
Substantial Shareholder Notice - RWL
10-Jan-2018
Substantial Shareholder Notice - Elixinol
8-Jan-2018
EXL begins trading on ASX
5-Jan-2018
ASX Market Release
5-Jan-2018
Pre-Quotation Disclosure Notice
5-Jan-2018
Corporate Governance Statement
5-Jan-2018
Securities Trading Policy
5-Jan-2018
Equity Plan Rules
5-Jan-2018
Hemp Foods Aust Pty Ltd Accounts FY 2015, 2016 and 2017
5-Jan-2018
Elixinol Pty Ltd Accounts HY 2017
5-Jan-2018
Elixinol Pty Ltd Accounts FY 2016
5-Jan-2018
Elixinol LLC Accounts FY 2015, 2016 and HY 2017
5-Jan-2018
Constitution
5-Jan-2018
Appendix 1A and Information Form and Checklist
5-Jan-2018
Top 20 Shareholders
5-Jan-2018
Distribution Schedule
5-Jan-2018
Prospectus
5-Jan-2018
ASX Market Release - Admission to Official List